These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1227301)

  • 1. Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.
    Schecter A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):433-42. PubMed ID: 1227301
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences with Naltrexone in Buffalo.
    Taintor Z; Landsberg R; Wicks N
    Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies.
    Schecter AJ; Friedman JG; Grossman DJ
    Am J Drug Alcohol Abuse; 1974; 1(2):253-69. PubMed ID: 4467728
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 7. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing success in an antagonistic treatment program.
    Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
    NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
    Lewis DC
    Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone: the clinical investigator's dilemma.
    Ling W
    NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy.
    Callahan E; Rawson R; Glazer M; McCleave B; Arias R
    NIDA Res Monogr; 1976 Sep; (9):150-7. PubMed ID: 794716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craving in heroin addicts maintained on the opiate antagonist naltrexone.
    Sideroff SI; Charuvastra VC; Jarvik ME
    Am J Drug Alcohol Abuse; 1978; 5(4):415-23. PubMed ID: 755381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and behavior therapy for heroin addiction.
    Rawson RA; Glazer M; Callahan EJ; Liberman RP
    NIDA Res Monogr; 1979 Jun; (25):26-43. PubMed ID: 117373
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 17. Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.
    Verebey K; Mulé SJ
    Am J Drug Alcohol Abuse; 1975; 2(3-4):357-63. PubMed ID: 1227297
    [No Abstract]   [Full Text] [Related]  

  • 18. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 19. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of heroin dependence with naltrexone.
    Martin WR
    Curr Psychiatr Ther; 1975; 15():157-61. PubMed ID: 1181122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.